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Abstract
Pericyte and vascular smooth muscle cell (SMC) recruitment to the developing vasculature is an important step in blood
vessel maturation. Brain-derived neurotrophic factor (BDNF), expressed by endothelial cells, activates the receptor tyrosine
kinase TrkB to stabilize the cardiac microvasculature in the perinatal period. However, the effects of the BDNF/TrkB signaling
on pericytes/SMCs and the mechanisms downstream of TrkB that promote vessel maturation are unknown. To confirm the
involvement of TrkB in vessel maturation, we evaluated TrkB deficient (trkb2/2) embryos and observed severe cardiac
vascular abnormalities leading to lethality in late gestation to early prenatal life. Ultrastructural analysis demonstrates that
trkb2/2 embryos exhibit defects in endothelial cell integrity and perivascular edema. As TrkB is selectively expressed by
pericytes and SMCs in the developing cardiac vasculature, we generated mice deficient in TrkB in these cells. Mice with TrkB
deficiency in perivascular cells exhibit reduced pericyte/SMC coverage of the cardiac microvasculature, abnormal
endothelial cell ultrastructure, and increased vascular permeability. To dissect biological actions and the signaling pathways
downstream of TrkB in pericytes/SMCs, human umbilical SMCs were treated with BDNF. This induced membranous
protrusions and cell migration, events dependent on myosin light chain phosphorylation. Moreover, inhibition of Rho
GTPase and the Rho-associated protein kinase (ROCK) prevented membrane protrusion and myosin light chain
phosphorylation in response to BDNF. These results suggest an important role for BDNF in regulating migration of TrkB-
expressing pericytes/SMCs to promote cardiac blood vessel ensheathment and functional integrity during development.
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Introduction
During late embryonic development, the formation of mature
and fully functional blood vessels depends on the tightly regulated
association of endothelial cells and mural cells such as pericytes
and smooth muscle cells (SMCs). Many growth factors, such as
vascular endothelial growth factor (VEGF), regulate endothelial
cell migration and survival whereas platelet derived growth factor
(PDGF) is involved in the regulation of remodeling and maturation
of blood vessels via actions on pericytes and smooth muscle cells
[1].
Pericytes/SMCs are adventitial cells located within the base-
ment membrane of capillaries and post-capillary venules. These
contractile cells play an important role in stabilizing nascent
endothelial tubes by providing essential survival factors [2],
inhibiting endothelial cell proliferation, and guiding vessel wall
remodeling in response to growth factors [3]. Pericytes/SMCs are
intimately associated with endothelial cells through the extension
of cytoplasmic processes. Reciprocal interactions between endo-
thelial cells and pericytes/SMCs have been well characterized in
terms of growth factor-receptor signaling by PDGF. PDGF is
expressed by endothelial cells and binds to PDGF receptor b
(PDGFRb) on the surface of developing pericytes in immature
blood vessels. Genetic deletions of pdgf or pdgfrb result in perinatal
lethality, as a consequence of vascular dysfunction caused by
mural cell deficiency [4,5]. However, the molecular mechanisms
that regulate the recruitment of pericytes/SMCs, and the
extension of pericyte processes to provide coverage of microvas-
cular endothelial cells and vascular integrity are incompletely
understood.
Numerous studies have described critical roles for neurotrophins
and their receptors in non-neuronal cells, such as endothelial cells,
smooth muscle cells, immune cells, and epithelial cells in different
organs [6–9,11]. BDNF deficiency results in reduction in
endothelial cell-cell contacts and in endothelial cell apoptosis,
whereas BDNF overexpression results in increased capillary
density, establishing the essential role of BDNF in modulating
cardiac microvascular endothelial cells during cardiac develop-
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ment [10]. More recent studies confirm that BDNF mediates these
effects during development by activating its receptor tyrosine
kinase TrkB [11]. BDNF plays a critical role in regulating both
vascular development and the vascular response to injury. Unlike
VEGF-A, which activates the receptors VEGFR1 and VEGFR2
expressed on most endothelial cell populations and is critical for
early stages of vascular development, BDNF is expressed in an
organ-specific manner, restricted to the heart and skeletal muscle
vasculature during the perinatal period [10]. Endothelial cells
lining arteries and capillaries of the heart express BDNF, first
detectable in mid to late gestation and maintained into adulthood.
TrkB expression has been localized to perivascular cells in the
developing heart (E18.5), and in the smooth muscle cell layer of
coronary vessels [10]. Mice deficient in BDNF (bdnf 2/2) exhibit
impaired survival of endothelial cells in intramyocardial arteries
and capillaries in the late gestational and early postnatal periods
[10]. Vascular hemorrhage in neonatal bdnf 2/2 mice is restricted
to cardiac vessels, reflecting the localized expression of BDNF and
its receptor TrkB in the cardiac and skeletal muscle vasculature
[10]. Genetic disruption of trkb leads to lethality during late
embryonic development [11,12], but the cause of the early death is
unknown.
Here we demonstrate that TrkB is required for the development
of the cardiac microvasculature, and trkb2/2 embryos exhibit a
specific deficiency in pericytes/SMCs. Ultrastructural analysis
shows that trkb2/2 embryos have defects in endothelial cell
integrity including discontinuity of the cell membrane, leading to
perivascular edema. We also determined that pericyte/SMC-
specific deletion of TrkB results in abnormalities of vasculogenesis
that significantly contribute to the lethal phenotype observed in
trkb2/2 mice. Conditional TrkB deletion in SMCs results in
marked reduction of pericyte/SMC density in the heart and
perinatal lethality. Using cultured SMCs, we further identified that
BDNF/TrkB signaling leads to cell migration and contractile force
generation by actomyosin phosphorylation, to play a pivotal role
in regulating pericyte morphology and migration.
Materials and Methods
Trkb Null and trkb Floxed Animals
Heterozygous trkb (+/2) mice (Jackson Laboratories, Jax Stock
#003098) on a C57Bl/6 background were intercrossed to
generate homozygous animals. For embryo analysis, the gesta-
tional age was determined by morphological criteria including
limb bud, eye development, length, and weight of the embryo.
The genotypes of embryos or neonates were determined using tail-
derived DNA and PCR amplification as described by Jackson
Laboratories. Trkb floxed (trkbf/f) animals were generated as
described previously [13]. Briefly, exon 1 of the trkb gene, which
encodes the signal peptide and the first 40 amino acids of the N
terminus of TrkB, was floxed. Crossing a trkb f/f mouse with a
transgenic mouse carrying Cre driven by a smooth muscle actin
promoter (SMC-Cre, Jax Stock #004746), generated progeny in
which the expression of trkb was selectively eliminated in
perivascular cells including pericytes/SMCs. The genotype of
each animal was assessed using PCR of genomic DNA isolated
from tail, utilizing trkB.flox forward primers 59 TGG TGT ACT
GAG CCT TCT CCA G 39 and trkB.flox reverse primers 59 CGA
GGC TTG GAG TTG ACT GGT 39. All animal procedures of
this study were approved by the IACUC of Weill Cornell Medical
College and all efforts were made to minimize animal suffering.
Tissue Analysis
Following sacrifice, embryos were immediately fixed in 3%
paraformaldehyde in PBS for 18 hours. Dissected tissues were
embedded in paraffin for histological analysis for hematoxylin-
eosin staining, or infiltrated with 30% sucrose in PBS prior to
cryoprotection in 30% sucrose:OCT (1:1; Tissue Tek, Sakura, CA)
for immunohistochemical analysis. For electron microscopic
analysis, embryos and newborn mice were sacrificed by decapi-
tation and hearts were immediately removed from the chest cavity
and fixed in Karnovsky’s fixative solution for 18 hours prior to
embedding in Epon. One mm sections were stained with toluidine
blue for initial evaluation, followed by ultra-thin sections that were
counterstained with lead citrate and viewed with a JEOL electron
microscope. To analyze vascular permeability, FITC-dextran
(70 kD; Sigma) was injected as a bolus through the tail vein of 3-
month-old mice. After perfusion for 10 minutes, the animals were
sacrificed and hearts harvested and processed for fluorescence
microscopy. FITC-dextran intensity was quantified by densitom-
etry using ImageJ software.
qRT-PCR
RNA from the hearts of 3 to 6 week old mice was extracted
using RNeasy Plus Mini Kit (Qiagen) according to the manufac-
turer’s instructions. cDNA from total RNA was generated using
random hexamers and Superscript III (Invitrogen). qPCR for the
mouse trkb gene was performed using PerfeCTa SYBR Green
FastMix ROX (Quanta Biosciences) and the thermocycler ABI
Prism 7900 HT (Applied Biosystems). At least 5 mice of each
genotype were evaluated using primers that annealed to sequences
in exon 5 (59-ACTGCCTCAATGAGAGCAGC-39) and exon 6
(59-GGAAAGGGTCACAGACTTTCC-39), present in all trkb
transcripts. The level of expression of trkb mRNA in gene-targeted
animals was calculated as the fold change relative to the expression
level of trkb in the corresponding wild type littermate. Relative
mRNA expression level for each sample was normalized to the
actin gene and 18S ribosomal RNA as reference genes.
Immunohistochemical Analysis
For postnatal tissue, 10 micron serial frozen sections were
stained with NG2 antibody (Cat# AB5320, Millipore, MA) or
CD31/PECAM (BD Pharmingen, CA, clone MEC13.3, 5 mg/ml)
to detect pericytes/SMCs or endothelial cells, respectively. We
used isolectin B4 (Cat# B-1205, Vector Laboratories) to identify
endothelial cells and PDGFRb (Cat# AB91066, Abcam) for
pericytes/SMCs in embryos. The TrkB antibody was purchased
from Millipore (Cat# 07–225). The collagen IV antibody was
from Abcam (Cat# Ab6586). Collagen intensity was quantified by
densitometry using ImageJ software. For double-immunofluores-
cence, frozen sections were incubated with primary antibodies
overnight, followed by incubation with either Alexa 488 or 568
conjugated secondary antibodies (Invitrogen, NY) at room
temperature and visualized using a Zeiss microscope. Fluorescence
field images were captured digitally (Obzerver.Z1 microscope,
AxioCamMrm camera, Zeiss). Counts of NG2 or PDGFRb and
PECAM objects in the heart were performed after unbiased
intensity and size selection criteria. A gray level threshold was
selected for all the microphotographs of all different treatments
and staining. After this selection, ImageJ (Image J 1.34j; US
National Institutes of Health, Bethesda, MD, USA, (http://rsb.
info.nih.gov/ij/) particle analysis plug-in was used to set the lower
and higher size of pixels to be considered as a countable object.
Both selection thresholds were arbitrarily defined, but maintained
rigorously for all the images of different conditions. Finally, objects
were counted in each image using the ImageJ cell counter plug-in.
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NG2, PDGFRb and PECAM intensity was analyzed by
densitometry. To further ensure absence of bias in object counting
or densitometry analysis, sections were coded, and the operator
was blind to treatment groups. Negative controls without primary
antibodies were performed for each immunodetection.
Scratch-migration Assay
Human umbilical smooth muscle cells (HuSMCs) were isolated
as described previously [14] and cultured in DMEM with 10%
fetal bovine serum (FBS). HuSMCs were obtained through
Institutional Review Board-approved protocols (Weill Cornell
Medical College). HuSMCs (passage 7) were seeded in duplicate
on 6-well plates at 16106 cells per well, and grown to confluency.
Cells were incubated at 37uC in 5% CO2. Prior to treatment, cells
were placed in DMEM without FBS for 18 hours. A vertical
scratch through the plate was made gently using a 1 ml pipette tip.
Following scratching, plates were washed with media to remove
floating cells and debris. BDNF (100 ng/ml) was added to fresh
media without FBS and cells were photographed at 6, 13 and 24 h
followed by area analysis of the scratch using ImageJ. The width
and area of each scratch in each condition was analyzed in 7–10
random and separate fields (phase contrast, 5X, microscope Zeiss
Axiovert 200 M).
Live Imaging using Time-lapse Differential Interference
Contrast (DIC) Microscopy
HuSMCs were plated on glass bottom dishes (MatTek
Corporation) and cultured in DMEM containing 10% FBS for
24 hours. Medium was changed to serum-free DMEM overnight.
Cells were then imaged in phenol red-free DMEM (Invitrogen)
supplemented with 30 mM HEPES-NaOH (pH 7.4) using an
Olympus IX71 inverted microscope driven by IPLab software (BD
Biosciences) and equipped with a 60X PlanApoN objective (NA
1.42), a Hamamatsu EM-CCD camera and a heated stage
maintained at 37uC. Images were captured every 15 seconds. Cells
were treated with BDNF (100 ng/ml). For inhibitor studies, cells
were pre-treated with 10 mM Y-27632 (Cat# 688001, Millipore)
or 10 nM K-252a (Cat# 420297, Millipore) for 45 minutes, or
pre-incubated with 1 mg/ml C3 transferase (Cat# CT04, Cyto-
skeleton Inc.) for 4 hours. All movies were exported and processed
using IPLab (BD Biosciences) and ImageJ (NIH) software.
Western Blot Analysis
HuSMCs were lysed in TNE buffer (10 mM Tris, pH 7.8, 1%
Nonidet P-40, 0.15 M NaCl, 1 mM EDTA, protease inhibitor
cocktail (Sigma) and phosphatase inhibitors (Sigma)) for 30
minutes at 4uC. 100 mg of total cell lysate protein was loaded on
SDS-polyacrylamide gel and proteins were resolved and trans-
ferred to PVDF membrane. The following primary antibodies
were used: TrkB (Cat# 07–225, Millipore), AKT (Cat# 46915,
Cell Signaling Technology), phospho-AKT (Cat# 92715, Cell
Signaling Technology), ERK (Cat# 46955, Cell Signaling
Technology), phospho-ERK (Cat# 57265, Cell Signaling Tech-
nology), MLC (Cat# 3672, Cell Signaling Technology), and
phospho-MLC (Cat# 3674, Cell Signaling Technology) antibod-
ies. Anti b-actin (Cat# A-5441, Sigma) was used as a loading
control. The respective secondary antibodies (anti-rabbit or anti-
mouse IgG) were conjugated with HRP. Chemiluminescence of
the blots was detected using ECL Advance Western Blotting
Detection kit.
TrkB Knockdown using shRNA Lentiviral Vectors
Lentiviral plasmids containing shRNA against human TrkB
(targeting sequence: AATGCTCGCAAGGACTTTCAT; a kind
gift of Dr. Simon S. Murray, The University of Melbourne,
Australia) and a scramble control were obtained from Open
Biosystems Thermo Scientific (Waltham, MA, USA). Lentivirus
was packaged by co-transfection of shRNA constructs with
packaging plasmids pMD2.G and pCMV-dR8.9 using TransIT-
LT transfection reagent (Mirus, Madison, WI, USA) into
HEK293FT cells. Media was changed 24 h later, and the media
supernatant was collected 48 h after transfection. Supernatants
were filtered through a 0.45-mm filter and pelleted by centrifu-
gation with PEG-it (System Biosciences, Mountain View, CA,
USA). Pellets were resuspended in medium. HuSMCs were
infected, 72 h later media was changed to serum free, followed by
BDNF treatment (100 ng/ml). The efficacy of TrkB knockdown
was assessed by Western blot.
Results
trkb Gene Deletion Results in Embryonic Lethality and
Cardiac Vascular Defects
BDNF and TrkB are expressed in the developing cardiac
vascular bed with BDNF expressed by endothelial cells and TrkB
expressed prominently by pericytes and vascular smooth muscle
cells (SMCs) [10]. Furthermore, mice deficient in BDNF (bdnf 2/
2) exhibit severe cardiac vascular defects, leading to early
postnatal mortality [10]. To determine whether TrkB mediates
these effects, we generated trkb2/2 embryos and observed late
gestational lethality as early as embryonic day 17.5 (E17.5),
consistent with a prior report [12]. Defects within the heart and
vascular system are frequently responsible for in utero lethality of
the embryo and early fetus [15]. To identify the critical actions of
TrkB in the development of the cardiac vasculature prior to
lethality, we initially examined the cardiac morphology from
trkb2/2 or wild type littermates during late gestation. Histological
analysis of the hearts from E15.5 to E16.5 embryos showed
reduced ventricular wall thickness from the trkb2/2 embryos as
compared to wild type littermates, most prominently in the left
ventricular wall (Figure 1A, B). There were no significant
differences in overall heart size or the anatomical structure of
the heart (Figure 1A). Moreover, the great vessels appeared
normal in trkb2/2 compared to wild type littermates. This
phenotype is similar to that reported for the bdnf 2/2 mouse
[10]. However, the onset of intravascular hemorrhage was
detectable prenatally in trkb deficient embryos, whereas it occurs
postnatally (P0–P4) in mice with bdnf deficiency [10].
The ability of trkb2/2 embryos to survive until late gestation and
to form identifiable cardiac arteries, capillaries, and veins suggest
that the earlier processes of vasculogenesis and sprouting
angiogenesis are not greatly impaired. To establish the onset of
intramyocardial vessel defects, trkb2/2 embryos and wild type
littermates were examined from E14.5 to P0. Intramyocardial
hemorrhage in trkb2/2 embryos could be detected first at E16.5
(Figure 1C) and was present in E17.5 embryos (data not shown),
but it was absent in wild type littermates. The onset of hemorrhage
in late gestation suggests that TrkB is not required for the initial
stages of cardiac vasculogenesis and sprouting angiogenesis as
gene-targeted embryos with these defects typically die in utero
between embryonic days 9 and 13 [15].
We next investigated whether TrkB is required for the
development of the cardiac microvasculature. We compared the
vascular cell density in trkb2/2 and wild type embryos assessed by
double-immunolabeling for endothelial cells and pericytes/SMCs
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using isolectin B4 (IB4) and PDGFRb antibodies, respectively. At
E17.5, PDGFRb-positivity was significantly reduced in the left
ventricular wall of trkb2/2 embryos as compared to wild type
littermate controls (Figure 2A, D), showing decreased perivascular
coverage of the blood vessels in vivo (Figure 2E). To further
characterize the defects in vessel morphology in trkb2/2 mice,
ultrastructural analysis was performed on wild type and trkb2/2
E17.5 embryos. The majority of endothelial cells in arterioles and
capillaries in heart sections from trkb2/2 animals exhibited
degeneration and discontinuity of the plasma membrane, detach-
ment from the underlying basal membrane, and perivascular
edema (Figure 2G). No abnormalities were noted in endothelial
cells from wild type littermates (Figure 2F).
Together these results suggest that the establishment of the
cardiac vascular network, and its patterning to form veins,
arterioles, and capillaries, are not substantially perturbed in
trkb2/2 embryos. However, vascular hemorrhage in the heart is
detectable from E16.5 onwards during the developmental time
frame in which TrkB vascular expression normally commences
[10]. In addition to vascular defects, trkb2/2 embryos exhibited
abnormalities in ventricular wall thinning by E16.5 (Figure 1A)
that may be a secondary effect due to impaired blood flow.
Pericyte-specific Deletion of TrkB Exhibits Reduced
Pericyte Density
To investigate how TrkB modulates pericyte/SMC function
during the development of the cardiac vasculature, we generated
mice selectively deficient in trkb in pericyte/SMCs by crossing
floxed trkb mice (trkbf/f) [13] with smooth muscle cell alpha actin
(SM22a) Cre expressing mice (SMCCre). Heterozygous mutants
were generated and further intercrossed to obtain homozygous
embryos. Trkbf/f-SMCCre+ allele demonstrated 20% reduction in
Mendelian inheritance (expected ratio: 25%; observed ratio: 20%,
Table S1). In those trkbf/f-SMCCre+ embryos that survived, qRT-
PCR analysis of the heart RNA showed ,80% reduction of the
TrkB transcript compared to wild type-SMCCre+ littermates at
postnatal day 21 (Figure S1). In wild type mice, TrkB is expressed
by perivascular cells surrounding platelet endothelial cell adhesion
molecule positive (PECAM+) endothelial cells (Figure 3A). In
contrast, TrkB expression was markedly reduced in the majority of
pericytes/SMCs of the trkbf/f-SMCCre+, however, in a small
subset of perivascular cells TrkB expression was unaffected by the
conditional deletion (Figure 3A). This result suggests that
pericytes/SMCs represent the major source of TrkB in the
neonatal heart, and that TrkB expressed by pericytes promotes the
survival of the embryos.
We next quantified pericyte coverage of the cardiac microvas-
culature utilizing dual NG2 proteoglycan (pericyte/SMC marker)
and PECAM (endothelial marker) immunodetection to determine
whether deletion of TrkB results in loss of pericytes/SMCs. At
postnatal day 21, trkbf/f-SMCCre+ mice displayed a 50%
reduction in NG2+ perivascular cell density compared to the wild
type control mice (Figure 3B, C, D). Thus, the reduction in TrkB
expression in pericytes/SMCs resulted in a reduction of the
number of this cell population in developing vessels. However, the
total number of capillaries is unchanged in the trkbf/f-SMCCre+ as
shown by PECAM staining (Figure 3E, G), despite an increase in
PECAM intensity in those cells (Figure 3F).
To better understand the cellular basis of the vascular defects
observed in surviving trkbf/f-SMCCre+ mice, we examined the
cardiac vasculature at the ultrastructural level at postnatal day 21.
In wild type mice, the endothelial abluminal surface was free of
cytoplasmic extensions, and the basement membrane between
endothelial cells and pericytes was intact (Figure 4A). In contrast,
endothelial cells from trkbf/f-SMCCre+ mice exhibited loss of cell-
cell contact, perivascular edema, and loss of apposition of
endothelial cells and pericytes (Figure 4A). These ultrastructural
defects are similar to those observed in the trkb2/2 mice hearts,
although not as profound. We further studied key vascular
basement membrane components, and observed no significant
changes in the deposition of endothelium-derived basement
membrane proteins laminin c1 and fibronectin in trkbf/f-
SMCCre+ pericyte-deficient vessels (data not shown), but we
detected a significant reduction in collagen IV deposition as
compared with wild type-SMCCre+ mice (Figure 4B, C). These
results suggest an impairment of basement membrane synthesis in
Figure 1. Ventricular wall thinning and hemorrhage in trkb2/2 embryos. Embryos at the indicated gestational age were harvested from
trkb+/2 females. (A) Sections of the heart were analyzed following hematoxylin and eosin staining. Ventricular wall size was normal in mid-gestation in
the wild type animals, but thinning became apparent by E16.5 in the trkb2/2 embryos. The square inset represent the region were the ventricular wall
was quantified in (B). Scale bar = 300 mm. (B) Quantification of (A). Bars represent mean 6 s.e.m. n = 3 per group, where we analyzed 6 sections per
animal. Statistical comparisons were made by one-way analysis of variance test. *P,0.05. (C) Sections of the right ventricular wall were analyzed
histologically following hematoxylin and eosin staining. Intramyocardial hemorrhage from trkb2/2 embryos could be detected at E16.5 (arrowheads)
and was absent in wild type littermates. Scale bar = 50 mm.
doi:10.1371/journal.pone.0087406.g001
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the cardiac vasculature of trkbf/f-SMCcre+ mice. Lastly, perfusion
studies using FITC-dextran (70 kDa.) in 3-month-old mice,
demonstrated an increase in extracellular accumulation of the
dye around the pericyte/SMC-deficient vasculature of the trkbf/f-
SMCCre+ hearts (Figure 4D, E). Wild type-SMCCre+ mice were
used as controls in which no dextran particles were found around
arteries and capillaries of the hearts (Figure 4D, E). Taken
together, these results strongly suggest that TrkB maintains cardiac
microvascular homeostasis by recruiting pericytes/SMCs. The
lack of pericytes/SMCs in the trkbf/f-SMCCre+ mice leads to
vascular abnormalities noted by an increase in the accumulation of
dextran in the perivascular area, which is in agreement with
specific cellular defects observed by ultrastructural analysis and
reduced collagen IV deposition.
BDNF Regulates the Morphology and Migration of
Pericytes/SMCs through TrkB Activation
The reduction in immunodetection of pericytes/SMCs in trkb2/
2 and trkbf/f-SMCCre+ mice coupled with the ultrastructural
analysis suggesting a reduction in pericyte/SMC coverage allowed
us to hypothesize that TrkB regulates pericyte/SMCs migration
and/or ensheathment of endothelial cells. We investigated the role
of TrkB in pericyte/SMC migration using cultured human
umbilical smooth muscle cells (HuSMCs). HuSMCs express full
length TrkB, as shown by immunohistochemical staining
(Figure 5A) and western blot analysis (,140 kD, Figure 5B).
Truncated TrkB, which lacks tyrosine kinase activity, was not
detectable in these cells (data not shown). Using in vitro live
imaging, we observed acute morphological changes in HuSMCs in
response to BDNF compared to untreated control cells. Within 2
Figure 2. Microvessel abnormalities in trkb2/2 embryos. (A–D) Immunofluorescent staining using IB-4 (green) to detect endothelial cells and
PDGFRb (red) to detect pericytes, within the ventricular wall in wild type (A–C) and trkb2/2 (B–C) littermates at E17.5. High magnification images at
100X for wild type (C) and trkb2/2 (D). The PDGFRb staining is discontinuous and lacks close apposition to IB-4 in the trkb2/2 embryos (arrow) as
compared to the wild type embryos. Scale bar A, B = 20 mm. Scale bar C, D= 10 mm. (E) Quantification of (A–D). Bars represent mean 6 s.e.m.
n = 3 per group. Statistical comparisons were made by one-way analysis of variance test. *P,0.05. PDGFRb immunoreactivity in the trkb2/2 hearts is
reduced, as compared to the wild type hearts. (F,G) Electron-micrographs of ventricles from wild type (F) or trkb2/2 (G) embryos at E17.5. Endothelial
cells frequently exhibited degenerated plasma membrane (arrow head) and perivascular edema was consistently detected in capillaries and arterioles
of trkb2/2 embryos. Scale bar F,G = 2 mm.
doi:10.1371/journal.pone.0087406.g002
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to 5 minutes of BDNF addition, cells extend rounded cytoplasmic
protrusions (Figure 5C; Movie S1). In tumor cells such as
melanoma cells, cytoplasmic protrusions are associated with
amoeboid fast migration, and are initiated by actomyosin
contractility following RhoA activation [16]. BDNF-induced
cytoplasmic protrusions were inhibited by pre-treatment with the
Trk kinase inhibitor K252a (Figure 5C, D, Movie S2).
To directly evaluate the migration of HuSMCs in response to
BDNF, we performed a scratch assay of cultured cells and assessed
their migratory response to BDNF at multiple time points. BDNF
induced the migration of HuSMCs as compared to control
untreated cells at 6, 13 and 24 h (control scratch area in arbitrary
units 6 h= 49.964.7; BDNF 6 h= 43.361.5; control
13 h= 48.866.0; BDNF 13 h= 36.461.6; control
24 h= 52.9611.4; BDNF 24 h= 32.861.5; Figure 5E is showing
13 h of BDNF-induced migration). To confirm the involvement of
TrkB in BDNF-induced migration, we infected HuSMCs with
lentivirus expressing small hairpin RNA (shRNA) targeting TrkB.
TrkB shRNA expression resulted in partial but significant decrease
in TrkB protein levels as compared with the scrambled shRNA
control infection (Figure 5E). HuSMCs expressing shRNA for
TrkB exhibited reduced BDNF-induced migration (Figure 5E), a
Figure 3. Pericyte/SMCs-specific deletion of TrkB induces a reduction in pericyte density. (A) Double immunofluorescence staining of the
left ventricular wall from P21 mice. TrkB (red) is expressed by perivascular cells (PECAM in green) in wild type mice and is largely reduced in trkbf/f-
SMCCre+ littermates. (B–G) Quantification of NG2+ (B, C, D) and PECAM+ (E, F, G) cells and intensity in the heart. n= 3 per genotype. Bars represent
mean 6 s.e.m. Statistical comparisons were made by one-way analysis of variance test. (C) *: P = 0.0023. (D) *: P = 0.007. (F) *: P = 0.0022. Scale bar A,B
and E= 20 mm.
doi:10.1371/journal.pone.0087406.g003
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result that is in agreement with K252a inhibition of the BDNF-
induced migration shown by live imaging in vitro (Figure 5C, D).
To characterize the mechanisms by which BDNF/TrkB
activation in pericytes/SMCs modulates their morphological
changes and possible fast migration, we first evaluated the
potential mediators of cell migration downstream of TrkB by
examining the phosphoprotein profile in SMCs using the 4G10
antibody (pan-anti-phosphotyrosine). We observed phosphorylat-
ed proteins migrating at ,42 kDda in the BDNF-treated
HuSMCs as compared to untreated cells (data not shown).
Figure 4. Vascular abnormalities in the trkbf/f-SMCCre+ mice. (A) Electron micrographs of hearts of wild type-SMCCre+ and trkbf/f2 SMCCre+
mouse hearts at postnatal day 21. In the middle and right panel, cardiac capillaries show abluminal cytoplasmic protrusions (*), endothelial
degeneration with evidence of loss of cell-cell contact, perivascular edema and detachment in arteries and capillaries (arrow head) in the trkbf/f-
SMCCre+ mouse hearts as compared to control wild type-SMCCre+ littermates (left panel). Scale bar left and middle panel = 2 mm. Scale bar right
panel = 1 mm. N: Nucleus; EC: Endothelial Cell; P: Pericyte; R: red cell. (B) Reduction in Collagen IV deposition surrounding arterioles and microvessels
in the trkbf/f-SMCCre+ as compared to wild type-SMCCre+ hearts (PECAM in green and collagen IV in red). Scale bar = 20 mm. (C) Quantification of (B).
Bars represent mean6 s.e.m. n = 3 per group. Statistical comparisons were made by one-way analysis of variance test. *P,0.05. (D) FITC-dextran and
immunofluorescence analysis of sections corresponding to the left ventricular vasculature in trkbf/f2 SMCCre+ or wild type-SMCCre+ littermates at 3
months of age. IB4+ endothelial cells in the far red channel (white), NG2+ pericytes/SMCs in the red channel, FITC-dextran in the green channel, and
DAPI in the blue channel. Increased extracellular accumulation of the FITC-dextran dye around pericyte-deficient vasculature in the hearts of trkbf/f2
SMCCre+ mice, compared to wild type-SMCCre+ littermate controls. n= 3 per genotype. Scale bar = 20 mm. (E) Quantification of FITC-dextran in (D).
Bars represent mean 6 s.e.m. n = 3 per group. Statistical comparisons were made by one-way analysis of variance test. *P,0.05.
doi:10.1371/journal.pone.0087406.g004
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Reprobing of the membrane with specific antibodies, revealed that
BDNF treatment induces activation of Ras/mitogen-activated
protein kinases (ERK1/2) (Figure 6A, B). Klemke et al. (1997) have
reported that the interaction of cells with growth factors in the
extracellular matrix initiates ERK1/2 signaling leading to the
activation of the motility machinery by enhancing phosphorylation
of myosin light chain (MLC) [17]. Moreover, actomyosin
contractility in many cell types results from phosphorylation of
myosin light chain (MLC) downstream of the Rho kinases ROCK
I and II [16]. Therefore, we performed pharmacological inhibition
studies and observed that BDNF-induced cytoplasmic protrusions
were inhibited by pre-treatment with the Rho-associated protein
kinase (ROCK) inhibitor Y-27632, and the Ras homolog (Rho)
inhibitor C3 transferase (Figure 5D), suggesting that this effect is a
consequence of BDNF-TrkB signaling activation via the Rho/
ROCK pathway.
To determine whether BDNF regulates actomyosin contractility
in HuSMCs, we investigated the phosphorylation of MLC.
Immunofluorescence analyses of phospho-MLC from unstimu-
lated cells showed uniform and diffuse immunoreactivity, whereas
HuSMCs treated with BDNF exhibited significant increase in
phospho-MLC detection (Figure 6C). Analysis of phospho-MLC
by Western blot demonstrated a marked increase in response to
BDNF (Figure 6D, E). Furthermore, simultaneous treatment with
BDNF and the ROCK inhibitor Y-27632 reduced MLC
phosphorylation in the HuSMCs (Figure 6D, E). These results
suggest that activation of TrkB by BDNF in HuSMCs activates the
Rho/ROCK pathway to induce morphological changes associated
with migration in this cell population.
Together, these findings suggest that BDNF-TrkB can promote
pericyte/SMC migration via activation of actomyosin contractility
involving ERK1/2 and Rho/ROCK pathways (Figure 6F, G).
The significant decrease in pericyte coverage of endothelial cells
observed in trkbf/f-SMCCre+ mice may therefore be a conse-
quence of impaired migration of pericytes/SMCs, leading to
inadequate vascular ensheathment.
Figure 5. BDNF regulates the morphology and migration of human umbilical smooth muscle cells (HuSMCs). (A) Immunostaining of
HuSMCs with TrkB antibody. Scale bar = 10 mm. (B) Western blot analysis for TrkB expression in HuSMCs. Lysate of rat cortical neurons in culture for
6 days was used as positive control for TrkB expression. (C) Phase contrast micrographs at different time points of HuSMCs treated with BDNF, and
K252a+BDNF. and BDNF, The arrow heads represent membrane protrusions induced by BDNF. Scale bar = 20 mm. (D) Quantification of (C), and
reactivity of HuSMCs after treatment with Y27632 (ROCK inhibitor) and BDNF, or C3 transferase (Rho inhibitor) and BDNF. n control = 9; n BDNF= 8; n
K252a+BDNF=7; n Y27632+BDNF= 10; n C3+BDNF= 7. (E) Scratch assay showing BDNF-induced HuSMCs migration 13 h after the addition of the
ligand. The experiment was repeated in triplicate in 3 independent experiments. Bars represent mean 6 s.e.m. Statistical comparisons were made by
one-way analysis of variance test with Duncan’s post hoc analysis. *P,0.05. (F) Western blot analysis showing reduced expression of TrkB after shRNA
knockdown.
doi:10.1371/journal.pone.0087406.g005
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Discussion
Coronary blood vessel development requires BDNF, as mice
deficient in this growth factor exhibit apoptosis of endothelial cells
in the heart, leading to vessel destabilization and myocardial
hemorrhage. These data raised the hypothesis that BDNF may act
as an autocrine factor on endothelial cells or in a paracrine
manner to induce activation of TrkB on neighboring pericytes, to
stabilize nascent blood vessels. Here we establish the dependence
of the cardiac vasculature on TrkB-mediated pericyte/SMC
coverage of microvessels during development in vivo and SMCs
migration in vitro. The lack of pericyte investment around
endothelial cells in the cardiac capillaries and arterioles of TrkB
deficient mice resulted in vascular leakage and ultimately in
embryonic lethality. These studies identify a novel mechanism by
which a growth factor:receptor system regulates in a paracrine
manner the pericyte coverage, stability and homeostasis of the
cardiac microvasculature.
During fetal embryogenesis, pericyte/SMC expressing
PDGFRb are recruited along the developing vascular endothelial
tubes expressing PDGFB, results that are supported by pdgfb and
pdgfrb knockout mice which lack desmin-positive perivascular cells
[4,5]. Moreover, PDGFB expressed by the endothelium induces
proliferation and migration of pericyte/SMC progenitors in early
developmental stages. Later in development, blood vessels
undergo vessel maturation, but the signals that govern this
maturation are not well defined. Our data demonstrates that a
subpopulation of PDGFRb+ cells that co-express TrkB receptor
are important to induce pericyte/SMC coverage which is essential
for the blood vessel maturation and homeostasis in later stages of
development. TrkB deficiency can explain the impaired recruit-
ment of pericytes/SMCs to the nascent vasculature; however,
other differences such as pericyte cell death in the trkb2/2 mice
may also have a role. Indeed, a previous report showed increased
Tunnel labeling in the subepicardium of TrkB deficient embryos
as compared to their wild type littermates at E12.5, although the
identity of the apoptotic cells was not determined [11]. This report
also showed a reduction of subepicardial capillaries in TrkB-
deficient mice using markers for vascular endothelial cells [11].
Our studies extend this prior report by demonstrating a reduction
of the left ventricular wall thickness in trkb2/2 (Figure 1A, B) and
endothelial cell degeneration by electron microscopy (Figure 2G).
Whereas developmental deletion of TrkB in all cells resulted in
embryonic lethality as noted here and in prior studies [11,12],
conditional deletion of TrkB in pericytes/SMCs resulted in a
,20% lethality of trkbf/f-SMCCre+ progeny. Notably, despite in
the loss of coverage by cardiac pericytes, we found that 80% of the
trkbf/f-SMCCre+ mice survived to adulthood and reached
reproductive age. This could be explained by the partial decrease
(,80%) in trkb mRNA in the trkbf/f-SMCre+ mice heart (Figure
Figure 6. Signaling pathways involved in TrkB-BDNF-induced migration of HuSMCs. (A) ERK1/2 phosphorylation 30 minutes after BDNF
administration to HuSMCs. (B) Quantification of (A) normalized to total ERK. Bars represent mean 6 s.e.m. n= 3 per group. Statistical comparisons
were made by one-way analysis of variance test. *P,0.05. (C) phosphor-MLC (green) after 1 hour of BDNF addition to HuSMCs. Representative
images of 3 independent experiments. Scale bar = 20 mm. (D) Western blot showing MLC phosphorylation after 1 hour of BDNF addition (with or
without the Y27632 ROCK inhibitor) to HuSMCs. (E) Quantification of (D) normalized to total MLC. Bars represent mean 6 s.e.m. n = 3 per group.
Statistical comparisons were made by one-way analysis of variance test with Duncan’s post hoc analysis. *P,0.05. (F–G) Proposed model of TrkB/
BDNF signaling role in the cardiac microvasculature. (F) When TrkB/BDNF signaling is present, pericytes migrate in an ERK1/2, Rho/ROCK, and MLC-
dependent manner to ensheath the endothelial cells in capillaries. This pericyte coverage of the endothelium promotes mature and stable capillaries.
(G) In the absence of TrkB/BDNF signaling, pericytes do not cover the nascent vessels and the resulting capillaries are unstable and leaky.
doi:10.1371/journal.pone.0087406.g006
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S1). This incomplete deletion may be due to variable Cre
recombination, but it has also been suggested that pericyte/SMC
within the same organ arise from different embryonic origins [18],
and we only have targeted a subset of pericytes/SMCs that express
the transgelin promoter (smooth muscle protein 22-alpha). This
could result in other pericytes/SMC compensating for the loss of
the smooth muscle protein 22-alpha+ cells and promoting a less
drastic phenotype compared with the trkb mice. Lastly, the TrkB
receptor could be expressed on other non-vascular cells that can
contribute to the unpredicted trkbf/f-SMCCre+ mice survival.
Our studies suggest that the extracellular matrix expressed by
pericytes affects vascular stabilization. Extracellular matrix depo-
sition regulates the transition from vascular morphogenesis to
maturation [1]. Discontinuous or absent basement membrane can
lead to blood vessel abnormality and instability. It has been shown
that pericytes in vitro express numerous basement membrane
components, such as collagen IV, laminin, and fibronectin. Studies
by Stratman and colleagues [19] have shown that pericyte
recruitment to endothelial cell-lined tubes during vasculogenesis
is a stimulatory event controlling vascular basement membrane
matrix assembly. Their study demonstrates an induction of the
basement membrane components fibronectin, nidogen-1, perle-
can, collagen IV, collagen VIII, and several laminin isoforms [19].
In accordance with their studies, our results show in vivo that a
reduction in pericyte number leads to decreased deposition of
collagen IV in mice with TrkB deficiency in pericytes/SMCs.
These data suggest that active communication between pericytes
and endothelial cells through BDNF/TrkB signaling pathways
regulates extracellular matrix deposition.
Our results suggest that conditional TrkB deletion in pericytes/
SMC impedes the recruitment of these cells to the microvascu-
lature. To identify signaling pathways mediating these effects we
used HuSMCs in culture and showed that BDNF-TrkB activation
leads Rho GTPases activation (Rho/ROCK pathway), Erk1/2
and MLC phosphorylation and the consequently migration of the
cells. Rho GTPases and MLC have been described as key
regulators of pericytes/SMC shape and contractility [17,20–21].
Furthermore, Kutcher and collaborators [22] have shown that the
Rho GTPase-signaling pathway modulates capillary endothelial
cell proliferative status and pericyte-endothelial cell interaction
in vitro which is in agreement with our results.
Dysfunction in pericyte/SMC migration has been reported in
many microvascular diseases, such as hypertension and diabetic
microangiopathy. Therefore, it is of great importance to better
understand the mechanisms by which pericytes regulate micro-
vessel function.
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